Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now early-phase tilt

Drug Use: early-phase trial registry

7 of 26 indexed Drug Use trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #627 of 28,707 conditions by registered trial count.

26 US clinical trials · 7 currently recruiting · #627 of 28,707 conditions by registered trial count

Drug Use: 26 US clinical trials tracked, 7 recruiting.

Drug Use is the subject of 26 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Michigan, running 4 of these trials.

Enrollment posture brief

Registry condition drug-use

OPEN 7 | RECR 27% | LATE 1 | EARLY 3 | RANK #627 | SPON 4

Nearest open-share peer: Metabolic Syndrome (27% recruiting · 104 trials)

Autoimmune Diseases53.8%Drug Use (this)27%Cancer Survivor26.9%Anaplastic Large Cell Lympho19.2%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Drug Use

Drug Use lists 7 open slots (27% of 26 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Drug Use on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Drug Use is recruiting below its size-band peers.

    7 of 26 indexed trials (26.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Drug Use research.

    University of Michigan accounts for 4 of 26 trials (15.4%). 17 distinct sponsors appear on at least one study for this condition label.

  3. Typical Drug Use enrolment sits around 180 participants.

    Median target enrolment is 180 among the 26 trials that report a genuine target (sentinel values excluded). 13 of those (50%) plan for fewer than 100 participants.

  4. Drug Use research is mostly interventional.

    26 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22Phase 41

Open and recent trials

26 total, page 1 of 1

RECRUITING NA 468 participants

Mental Health in Primary Care

University of Miami

NCT05426057

RECRUITING NA 360 participants

Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation

Johns Hopkins University

NCT06103370

RECRUITING NA 306 participants

Families With Pride ("Familias Con Orgullo").

University of Miami

NCT06057337

RECRUITING NA 200 participants

Harm Reduction Services

NYU Langone Health

NCT05776316

RECRUITING Phase 2 180 participants

Family Acceptance Project Online (Pilot RCT)

University of Michigan

NCT06839859

RECRUITING NA 60 participants

Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents

University of Rhode Island

NCT05380765

RECRUITING NA 28 participants

Lakota Family Acceptance Project

University of Michigan

NCT07326748

ACTIVE NOT RECRUITING NA 458 participants

mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care

University of California, Los Angeles

NCT04935606

ACTIVE NOT RECRUITING NA 405 participants

Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care

Johns Hopkins University

NCT04601064

ACTIVE NOT RECRUITING NA 220 participants

A Hybrid Effectiveness Implementation Study of Latino/a Alcohol and Drug Users

Boston University Charles River Campus

NCT04771650

COMPLETED NA 1,072 participants

Evaluation of Respecting the Circle of Life on Pregnancy Prevention Outcomes Among American Indian Adolescents

Johns Hopkins Bloomberg School of Public Health

NCT02904629

COMPLETED Phase 1 442 participants

Acute Intervention to Reduce Distress Following Sexual Assault

Medical University of South Carolina

NCT01622855

COMPLETED NA 354 participants

Multimedia WORTH With Black Drug-Involved Women on Probation

Columbia University

NCT02391233

COMPLETED NA 294 participants

Alcohol Screening in an Ethnically Diverse Sample of Adolescents in Primary Care

RAND

NCT01797835

COMPLETED NA 196 participants

Prevention and Risk: Treatment With a New Emphasis on Relationships

Hunter College of City University of New York

NCT03396367

COMPLETED NA 97 participants

Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions

Treatment Research Institute

NCT02059005

COMPLETED Phase 2 71 participants

Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections

Laura Fanucchi

NCT04677114

COMPLETED NA 65 participants

Intergenerational Strengths-Based Program for American Indian Girls as They Transition to Adulthood

Johns Hopkins Bloomberg School of Public Health

NCT03900312

COMPLETED NA 63 participants

Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER

University of Michigan

NCT03079856

COMPLETED NA 50 participants

Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention

University of Michigan

NCT03855410

COMPLETED NA 49 participants

Testing the Effectiveness of a Graphic Novel Health Education Curriculum for Patients With Addiction

Treatment Research Institute

NCT02378181

COMPLETED NA 39 participants

Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care

Johns Hopkins Bloomberg School of Public Health

NCT01941108

COMPLETED NA 39 participants

HCV Seek, Test and Rapid Treatment for Young PWID

Weill Medical College of Cornell University

NCT03627546

COMPLETED NA 27 participants

Y2Prevent: Preventing Drug Use and HIV Through Empowerment, Social Support and Mentorship (Y2P)

Children's Hospital Los Angeles

NCT04504981

COMPLETED Phase 4 27 participants

Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program

University of Miami

NCT04650269

COMPLETED NA 21 participants

Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users

University of Washington

NCT03584282

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 4 1

Named interventions

Most-linked intervention names on Drug Use records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Streamlined HIV Testing Behavioral
1 trials
E-WORTH Behavioral
1 trials
HIV care Other
1 trials
Biktarvy 50Mg-200Mg-25Mg Tablet Drug
1 trials
Y2Prevent Behavioral
1 trials
Education Intervention Behavioral
1 trials
PARTNER Behavioral
1 trials
Health Education Toolkit Behavioral
1 trials

US sites by state

Facility locations filed on Drug Use trials. A trial with sites in several states counts in each.

New York 4 trials
Pennsylvania 3 trials
Michigan 3 trials
Maryland 3 trials
Florida 3 trials
California 3 trials
Arizona 2 trials
Washington 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Drug Use page

26 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Drug Use condition card totals 26 registered trials; most-linked intervention Streamlined HIV Testing; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.